Clinical Trials
16 trialsNCT00700414 2026-05-22
International Pediatric Adrenocortical Tumor Registry
St. Jude Children's Research Hospital
Recruiting
NCT04897321 2026-05-19
B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)
St. Jude Children's Research Hospital
Phase 1 Recruiting
NCT06607692 2026-04-14
LUPARPED
Fundación de investigación HM
Phase 1/2 Recruiting
NCT06006013 2026-02-18
Cabozantinib in Combination With Pembrolizumab for the Treatment of Patients With Locally Advanced, Metastatic, or Unresectable Adrenal Cortical Cancer
Emory University
Phase 2 Recruiting
NCT02721732 2026-01-29
Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT07072143 2025-07-18
PARTNER
Azienda Ospedaliera di Padova
Recruiting
NCT06279442 2025-02-12
Adrenal Project: Clinical and Epidemiological Characterization of Adrenocortical Carcinoma in a Brazilian Cohort
Latin American Cooperative Oncology Group
Recruiting
NCT03370718 2024-12-10
Cabozantinib in Treating Patients With Locally Advanced or Metastatic Unresectable Adrenocortical Carcinoma
M.D. Anderson Cancer Center
Phase 2 Completed
NCT03612232 2024-08-19
CaboACC
Wuerzburg University Hospital
Phase 2 Unknown
NCT06050057 2023-09-22
Surgical Treatment of Adrenal Diseases- Laparoscopic vs. Robotic-assisted Adrenalectomy
University Hospital Olomouc
Recruiting
NCT04890444 2022-02-14
CASE
Shanghai Jiao Tong University School of Medicine
Unknown
NCT04666220 2021-02-12
VETC, Prognostic and Predictive Value in Renal Cell Carcinoma and Adrenal Carcinoma
Humanitas Clinical and Research Center
Unknown
NCT02720484 2019-05-01
Nivolumab in Treating Patients With Metastatic Adrenocortical Cancer
Northwestern University
Phase 2 Terminated
NCT00215202 2018-05-17
Phase II Trial of ZD1839 (Iressa) in Patients With Nonresectable Adrenocortical Carcinoma (ACC)
Dartmouth-Hitchcock Medical Center
Phase 2 Completed
NCT02831179 2017-09-28
Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor
Vanderbilt-Ingram Cancer Center
Phase 1 Withdrawn
NCT00768365 2008-10-08
adrenal
Istanbul University
Completed